Viking Therapeutics Inc
LSE:0VQA
Viking Therapeutics Inc
LSE:0VQA
Price:
30.83
USD
-2.59%
Market Closed
Market Cap:
$3.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Viking Therapeutics Inc
LSE:0VQA
|
US |
|
White Mountains Insurance Group Ltd
NYSE:WTM
|
US |
|
Ithaca Energy PLC
F:XE3
|
UK |
|
K
|
Kronos Worldwide Inc
F:K1W
|
US |
|
L
|
London Stock Exchange Group PLC
DUS:LS4C
|
UK |
|
E
|
Essential Utilities Inc
SWB:A2A
|
US |
|
I
|
Ithaca Energy PLC
LSE:ITH
|
UK |
|
P
|
PennantPark Floating Rate Capital Ltd
NYSE:PFLT
|
US |
|
Sanofi SA
LSE:0A2V
|
FR |
|
D
|
Daito Trust Construction Co Ltd
SWB:4D7
|
JP |
|
A
|
Avex Inc
XMUN:AX8
|
JP |
|
Mediaalpha Inc
NYSE:MAX
|
US |
Wall St Price Targets
0VQA Price Targets Summary
Viking Therapeutics Inc
Viking Therapeutics Inc
Wall Street analysts forecast 0VQA stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 0VQA is 94.75 USD with a low forecast of 33.89 USD and a high forecast of 129.53 USD.
Lowest Forecast
Price Target
33.89
USD
10% Upside
Average Forecast
Price Target
94.75
USD
207% Upside
Highest Forecast
Price Target
129.53
USD
320% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0VQA's stock price target?
Price Target
94.75
USD
94.75
USD
According to Wall Street analysts, the average 1-year price target for 0VQA is 94.75 USD with a low forecast of 33.89 USD and a high forecast of 129.53 USD.
